Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia tightens blood screening against pathogens:

This article was originally published in Clinica

Executive Summary

The Australian Therapeutic Goods Administration (TGA) has instructed the Australian Red Cross Blood Service to introduce stricter controls for blood monitoring to guard against newly-emerging pathogens. These include SARS, the West Nile virus and the Dengue Fever virus. These pathogens have only recently been regarded as relevant to the blood transfusion and include infectious agents that were previously not considered to be transfusion transmitted. They may also contain other agents that require further study before their risk to the blood supply can be assessed, said the TGA.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062700

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel